Evidence map›Paper›PMID 39484672›Full record

ArticleNeuroSci2022

Neurocognitive Profiles of Caucasian Moyamoya Disease Patients in Greece: A Case Series.

Georgios Papageorgiou, Dimitrios Kasselimis, Georgia Angelopoulou, Dimitrios Tsolakopoulos, Nikolaos Laskaris, Argyro Tountopoulou, Eleni Korompoki, Georgios Velonakis, Achilles Chatziioannou, Konstantinos Spengos and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in NeuroSci, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Georgios PapageorgiouNeuropsychology and Language Disorders Unit, 1st Department of Neurology, National and Kapodistrian University of Athens, Eginition Hospital, 15772 Athens, Greece; dkasselimis@gmail.com (D.K.); georginangel@gmail.com (G.A.); dimitris_tsolakopoulos@hotmail.com (D.T.); cpotagas@otenet.gr (C.P.).
Dimitrios KasselimisNeuropsychology and Language Disorders Unit, 1st Department of Neurology, National and Kapodistrian University of Athens, Eginition Hospital, 15772 Athens, Greece; dkasselimis@gmail.com (D.K.); georginangel@gmail.com (G.A.); dimitris_tsolakopoulos@hotmail.com (D.T.); cpotagas@otenet.gr (C.P.).ORCID https://orcid.org/0000-0001-6324-0384
Georgia AngelopoulouNeuropsychology and Language Disorders Unit, 1st Department of Neurology, National and Kapodistrian University of Athens, Eginition Hospital, 15772 Athens, Greece; dkasselimis@gmail.com (D.K.); georginangel@gmail.com (G.A.); dimitris_tsolakopoulos@hotmail.com (D.T.); cpotagas@otenet.gr (C.P.).
Dimitrios TsolakopoulosNeuropsychology and Language Disorders Unit, 1st Department of Neurology, National and Kapodistrian University of Athens, Eginition Hospital, 15772 Athens, Greece; dkasselimis@gmail.com (D.K.); georginangel@gmail.com (G.A.); dimitris_tsolakopoulos@hotmail.com (D.T.); cpotagas@otenet.gr (C.P.).
Nikolaos LaskarisDepartment of Industrial Design and Production Engineering, School of Engineering, University of West Attica, 12243 Athens, Greece; nikolaos.laskaris@gmail.com.ORCID https://orcid.org/0000-0001-6838-6542
Argyro TountopoulouStroke Unit, 1st Department of Neurology, National and Kapodistrian University of Athens, Eginition Hospital, 15772 Athens, Greece; atounto@yahoo.gr (A.T.); e.korompoki@imperial.ac.uk (E.K.); svassilopoulou@gmail.com (S.V.).ORCID https://orcid.org/0000-0002-3276-588X
Eleni KorompokiStroke Unit, 1st Department of Neurology, National and Kapodistrian University of Athens, Eginition Hospital, 15772 Athens, Greece; atounto@yahoo.gr (A.T.); e.korompoki@imperial.ac.uk (E.K.); svassilopoulou@gmail.com (S.V.).
Georgios Velonakis2nd Department of Radiology, National and Kapodistrian University of Athens, 15772 Athens, Greece; giorvelonakis@gmail.com.ORCID https://orcid.org/0000-0002-0050-284X
Achilles Chatziioannou1st Department of Radiology, National and Kapodistrian University of Athens, 15772 Athens, Greece; achatzi@med.uoa.gr.
Konstantinos SpengosDepartment of Neurology, Hygeia Hospital, 15123 Athens, Greece; kspengos@hygeia.gr.
Constantin PotagasNeuropsychology and Language Disorders Unit, 1st Department of Neurology, National and Kapodistrian University of Athens, Eginition Hospital, 15772 Athens, Greece; dkasselimis@gmail.com (D.K.); georginangel@gmail.com (G.A.); dimitris_tsolakopoulos@hotmail.com (D.T.); cpotagas@otenet.gr (C.P.).
Sophia VassilopoulouStroke Unit, 1st Department of Neurology, National and Kapodistrian University of Athens, Eginition Hospital, 15772 Athens, Greece; atounto@yahoo.gr (A.T.); e.korompoki@imperial.ac.uk (E.K.); svassilopoulou@gmail.com (S.V.).

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The impact of Moyamoya Disease (MMD) on cognition inadult Caucasian patients has not yet been thoroughly investigated. The current study is the first to present detailed neuropsychological data on a series of Greek patients with MMD. A group of eight patients was assessed with an extensive neuropsychological battery, including measures of episodic memory, working memory, executive functions, language, and social cognition. The results indicated that MMD may be characterized by a trichotomous neurocognitive profile, characterized by prominent impairment in working memory, executive functions, and social cognition. Overall, we stress the need for a thorough cognitive evaluation of MMD patients and further highlight the potential importance of social cognition in this particular disease. Possible associations between the three impaired cognitive domains in our group are also discussed.

Indexed as

executive functionsmoyamoyasocial cognitionstrokeworking memory

Identifiers

PMID39484672
PMCPMC11523724

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.